Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis × Adrenal Cortex Hormones × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Prostatic Neoplasms 5 Brain Neoplasms 4 Radiation Injuries 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Hemangioma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Urogenital Neoplasms 1 Respiratory Distress Syndrome 1 Radiation Pneumonitis 1 Popliteal Cyst 1 Polycystic Ovary Syndrome 1 Pneumonia, Viral 1 Pneumonia 1 Optic Neuritis 1 Neoplastic Cells, Circulating 1 Neoplasms, Fibrous Tissue 1 Neoplasms, Connective and Soft Tissue 1 Neoplasms, Connective Tissue 1 Neoplasms by Histologic Type 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 Myelitis, Transverse 1 Myelitis 1 Myasthenia Gravis 1 Musculoskeletal Diseases 1

Interventions

Blood Specimen Collection 2 bavituximab 1 Ursodeoxycholic Acid 1 Surveys and Questionnaires 1 Steroids 1 Spermine Synthase 1 Sorafenib 1 Sofosbuvir 1 Ribavirin 1 Prednisone 1 Phlebotomy 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methylprednisolone 1 Liquid Biopsy 1 Clinical Protocols 1 Adrenal Cortex Hormones 1 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810156 2022-12-14

I-HEP

Herlev Hospital

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡